Advice on why and how based on Cleveland Clinic’s recent enterprise-wide transition
First-in-man trial demonstrates safety, promising functional response rates
Retrospective study finds benefits of ultra-early therapy extend to this understudied subgroup
Essentials of cerebral venous sinus thrombosis from a neurointensive care/stroke specialist
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Working with a dedicated cadre of stroke specialists helps curb cerebrovascular accidents
Singular research aims to enhance prediction of rupture
Hospital transfer compromises outcomes, and Target: Stroke proves its value
Advertisement
Advertisement